Trial Details
COMPLETEDBasic Information
| Clinical ID | c3810 |
|---|---|
| Identifier | NCT01496053 |
| Trial Title | Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease|Inflammatory Bowel Disease |
| Interventions | DIETARY_SUPPLEMENT: AndoSan|DIETARY_SUPPLEMENT: Sugar Extract |
Participant Information
| Sponsor | Oslo University Hospital |
|---|---|
| City | Oslo |
| Country/Region | Norway |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2011-12 |
|---|---|
| Primary Completion Date | 2015-12 |
| Completion Date | 2016-01 |